Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ
Status:
Recruiting
Trial end date:
2023-08-09
Target enrollment:
Participant gender:
Summary
The purpose of the study is to estimate the ability of mirtazapine to reduce depression,
nausea, and vomiting, and maintain weight in depressed glioma patients undergoing
Temozolomide (TMZ) therapy. Of equal importance, the investigators will monitor the
tolerability of Mirtazapine in these patients over the course of the study.